Barbara Rys
Registered Nurse · Warwick, NYNPI 1639377997
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 331 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,844 and has fallen 50.6% since, to $911 in 2025. Among registered nurse clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 331 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AstraZeneca$982
- GSK$568
- AbbVie$559
- Pfizer$509
- Novo Nordisk$502
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 45 | $1,110 |
| AstraZeneca | 54 | $982 |
| GSK | 28 | $568 |
| AbbVie | 25 | $559 |
| Pfizer | 27 | $509 |
| Novo Nordisk | 30 | $502 |
| Boehringer Ingelheim | 21 | $425 |
| Teva Pharmaceuticals USA, Inc. | 13 | $277 |
| Novartis | 10 | $265 |
| Bayer | 9 | $239 |
| Merck | 13 | $192 |
| Amarin Pharma, Inc. | 9 | $182 |
| Abbott | 6 | $111 |
| Bausch Health US, LLC | 5 | $86 |
| Currax Pharmaceuticals LLC | 6 | $78 |
| Astellas Pharma US Inc | 3 | $76 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $33 |
| Medtronic | 1 | $29 |
| Johnson & Johnson | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,674 in reported general payments places this provider in the 95th percentile of 446 registered nurse providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 29 | $32,640 |
| EliquisApixaban | 26 | $29,981 |
| MounjaroTirzepatide | 16 | $19,832 |
| JanuviaSitagliptin Phosphate | 19 | $16,458 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,471 |
| JardianceEmpagliflozin | 13 | $9,177 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,034 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,360 |
| Rosuvastatin Calcium | 249 | $2,924 |
| Levothyroxine Sodium | 245 | $2,274 |
| Bupropion XlBupropion Hcl | 36 | $1,859 |
| Omega-3 Acid Ethyl Esters | 12 | $1,627 |
| Pantoprazole Sodium | 66 | $997 |
| Metoprolol Succinate | 77 | $974 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 28 | $924 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $982 | $42,11044 claims |
| PfizerEliquis | $509 | $29,98126 claims |
| Lilly USA, LLCMounjaro | $1,110 | $19,83216 claims |
| MerckJanuvia | $192 | $16,45819 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $425 | $14,53724 claims |
| GSKTrelegy Ellipta | $568 | $9,03414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 446 registered nurse providers in New York.
Other registered nurse in Warwick
- Jane SeleyNew York$20K
- Chia-Wei LinBronx$15K
- Cathleen VarleyNew York$13K
- Hyojin KangOakland Gardens$7K
- Janet KelskeWest Bay Shore$6K
- Kathleen Foley RootSmithtown$5K
- Lisa Desjardins-RitchieGreat Neck$4K
- Hilary NierenbergNew York$4K
- Sharon JasekSyracuse$3K
- Sandra BastidasPort Washington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.